{"id":810299,"date":"2025-02-06T17:45:36","date_gmt":"2025-02-06T22:45:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/"},"modified":"2025-02-06T17:45:36","modified_gmt":"2025-02-06T22:45:36","slug":"dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/","title":{"rendered":"Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">EMERYVILLE, Calif.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Feb. 6, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4357658-1&amp;h=1762839823&amp;u=https%3A%2F%2Fwww.dynavax.com%2F&amp;a=Dynavax+Technologies+Corporation\" target=\"_blank\" rel=\"nofollow\">Dynavax Technologies Corporation<\/a> (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report fourth quarter and full year 2024 financial results on <span class=\"xn-chron\">Thursday, February 20, 2025<\/span>, after the U.S. financial markets close.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1273133\/Dynavax_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1273133\/Dynavax_Logo.jpg\" title=\"(PRNewsfoto\/Dynavax Technologies)\" alt=\"(PRNewsfoto\/Dynavax Technologies)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Dynavax will host a conference call and live audio webcast on <span class=\"xn-chron\">Thursday, February 20, 2025<\/span>, at <span class=\"xn-chron\">4:30 p.m. ET<\/span>\/<span class=\"xn-chron\">1:30 p.m. PT<\/span>.<\/p>\n<p>The live audio webcast may be accessed through the &#8220;Events &amp; Presentations&#8221; page on the &#8220;Investors&#8221; section of the Company&#8217;s website at\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4357658-1&amp;h=3443654989&amp;u=https%3A%2F%2Finvestors.dynavax.com%2Fevents-presentations&amp;a=https%3A%2F%2Finvestors.dynavax.com%2Fevents-presentations.\" target=\"_blank\" rel=\"nofollow\">https:\/\/investors.dynavax.com\/events-presentations.<\/a>\u00a0A replay of the webcast will be available for 30 days following the live event.<\/p>\n<p>To dial into the call, participants will need to register for the call using the\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4357658-1&amp;h=4180267413&amp;u=https%3A%2F%2Fregister.vevent.com%2Fregister%2FBI2d297bd1f37244b29ac17059a7375eed&amp;a=caller+registration+link\" target=\"_blank\" rel=\"nofollow\">caller registration link<\/a>. It is recommended that participants dial into the conference call or log into the webcast approximately 10 minutes prior to the call.<\/p>\n<p>\n        <b><br \/>\n          <u>About Dynavax <br \/><\/u><br \/>\n        <\/b>Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B<sup>\u00ae<\/sup> vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the U.S., the European Union and <span class=\"xn-location\">Great Britain<\/span> for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older, and CpG 1018<sup>\u00ae<\/sup> adjuvant, currently used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines. For more information about our marketed products and development pipeline, visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4357658-1&amp;h=2199530345&amp;u=https%3A%2F%2Fwww.dynavax.com%2F&amp;a=www.dynavax.com\" target=\"_blank\" rel=\"nofollow\">www.dynavax.com<\/a>.<\/p>\n<p>\n        <b>For Investors\/Media:<br \/><\/b><br \/>\n        <span class=\"xn-person\">Paul Cox<\/span><br \/>\n        <br \/>\n        <a href=\"mailto:pcox@dynavax.com\" target=\"_blank\" rel=\"nofollow\">pcox@dynavax.com<\/a><br \/>\n        <br \/>510-665-0499\u00a0<\/p>\n<p>\n        <span class=\"xn-person\">Nicole Arndt<\/span><br \/>\n        <br \/>\n        <a href=\"mailto:narndt@dynavax.com\" target=\"_blank\" rel=\"nofollow\">narndt@dynavax.com<\/a><br \/>\n        <br \/>510-665-7264<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=SF14092&amp;sd=2025-02-06\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025-302370741.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025-302370741.html<\/a><\/p>\n<p>SOURCE  Dynavax Technologies<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=SF14092&amp;Transmission_Id=202502061742PR_NEWS_USPR_____SF14092&amp;DateId=20250206\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire EMERYVILLE, Calif. , Feb. 6, 2025 \/PRNewswire\/ &#8212; Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report fourth quarter and full year 2024 financial results on Thursday, February 20, 2025, after the U.S. financial markets close. Dynavax will host a conference call and live audio webcast on Thursday, February 20, 2025, at 4:30 p.m. ET\/1:30 p.m. PT. The live audio webcast may be accessed through the &#8220;Events &amp; Presentations&#8221; page on the &#8220;Investors&#8221; section of the Company&#8217;s website at\u00a0https:\/\/investors.dynavax.com\/events-presentations.\u00a0A replay of the webcast will be available for 30 days following the live event. To dial into the call, participants will need to register for the call using the\u00a0caller registration link. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-810299","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire EMERYVILLE, Calif. , Feb. 6, 2025 \/PRNewswire\/ &#8212; Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report fourth quarter and full year 2024 financial results on Thursday, February 20, 2025, after the U.S. financial markets close. Dynavax will host a conference call and live audio webcast on Thursday, February 20, 2025, at 4:30 p.m. ET\/1:30 p.m. PT. The live audio webcast may be accessed through the &#8220;Events &amp; Presentations&#8221; page on the &#8220;Investors&#8221; section of the Company&#8217;s website at\u00a0https:\/\/investors.dynavax.com\/events-presentations.\u00a0A replay of the webcast will be available for 30 days following the live event. To dial into the call, participants will need to register for the call using the\u00a0caller registration link. &hellip; Continue reading &quot;Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-06T22:45:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1273133\/Dynavax_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025\",\"datePublished\":\"2025-02-06T22:45:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\\\/\"},\"wordCount\":287,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1273133\\\/Dynavax_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\\\/\",\"name\":\"Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1273133\\\/Dynavax_Logo.jpg\",\"datePublished\":\"2025-02-06T22:45:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1273133\\\/Dynavax_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1273133\\\/Dynavax_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/","og_locale":"en_US","og_type":"article","og_title":"Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025 - Market Newsdesk","og_description":"PR Newswire EMERYVILLE, Calif. , Feb. 6, 2025 \/PRNewswire\/ &#8212; Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report fourth quarter and full year 2024 financial results on Thursday, February 20, 2025, after the U.S. financial markets close. Dynavax will host a conference call and live audio webcast on Thursday, February 20, 2025, at 4:30 p.m. ET\/1:30 p.m. PT. The live audio webcast may be accessed through the &#8220;Events &amp; Presentations&#8221; page on the &#8220;Investors&#8221; section of the Company&#8217;s website at\u00a0https:\/\/investors.dynavax.com\/events-presentations.\u00a0A replay of the webcast will be available for 30 days following the live event. To dial into the call, participants will need to register for the call using the\u00a0caller registration link. &hellip; Continue reading \"Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-06T22:45:36+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1273133\/Dynavax_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025","datePublished":"2025-02-06T22:45:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/"},"wordCount":287,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1273133\/Dynavax_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/","name":"Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1273133\/Dynavax_Logo.jpg","datePublished":"2025-02-06T22:45:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1273133\/Dynavax_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1273133\/Dynavax_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dynavax-to-report-fourth-quarter-and-full-year-2024-financial-results-and-host-conference-call-on-february-20-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=810299"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/810299\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=810299"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=810299"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=810299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}